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ABSTRACT  
Large population-based research cohorts, together with national health registries and biobanks are core 
components in a modern infrastructure for knowledge. Along with the other Nordic countries, Norway has 
unique opportunities for high quality research based on cohorts, biobanks and registries. Cohorts, biobanks 
and registries provide a basis for discovering causes and mechanisms of disease as well as for following the 
development of disease, effects of treatment and consequences of disease. The purpose of this manuscript is 
to give a brief outline of a project that makes use of these unique opportunities by using data from The 
Norwegian Mother and Child cohort study (MoBa) to address research questions of common interest, and 
thus encourage other research groups to use this “happy hunting ground”. 
 The present study, Causal Pathways for Asthma (CASPAR) funded by the Research Council of Norway, 
is a subproject of MoBa. The project is designed to take advantage of the potential for research on human 
biological material in biobanks, by coupling analysis results with data from health surveys, health registries 
and the health services. The present study is based on an ongoing collaboration between the Norwegian In-
stitute of Public Health (NIPH), the National Institute of Environmental Health Sciences (NIEHS) in the US 
and several other national and international collaborators within The MoBa Asthma Group. The main aim of 
the study is to examine a number of hypothesis regarding in utero and early life exposures in relation to the 
development of different phenotypes of asthma and allergies in childhood. 
 For the majority of children who become asthmatic and allergic, the differentiation of their immune sys-
tem into an atopic phenotype probably begins before birth and is established within the first six years of life. 
This study will advance knowledge of the mechanisms whereby diet and environmental exposures influen-
ces gene expression to alter risk of atopic disease. The prime purpose is to build up new knowledge on 
asthma pathogenesis. There is a great need to develop a new paradigm of disease pathogenesis that takes 
advantages of applied molecular approaches to asthma and atopic diseases as it occurs in humans at different 
stages of development. This project takes advantage not only of the basic MoBa samples and infrastructure 
including links to other national health registries, but also a new national supplementary study of MoBa that 
includes measures of prenatal exposures in maternal plasma believed to have epigenetic influences on 
asthma/atopy development and data on genome wide methylation of cord blood DNA. 
 
This is an open access article distributed under the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
 
 
INTRODUCTION 
 
Large population-based research cohorts, together with 
national health registries and biobanks are core com-
ponents in a modern infrastructure for knowledge. 
Along with the other Nordic countries, Norway has 
unique opportunities for high quality research based on 
cohorts, biobanks and registries. Cohorts, biobanks and 
registries provide a basis for discovering causes and 
mechanisms of disease as well as for following the de-
velopment of disease, effects of treatment and conse-
quences of disease. The purpose of this manuscript is 
to give a brief outline of a project that makes use of 
these unique opportunities by using data from The 
Norwegian Mother and Child cohort study (MoBa) to 
address research questions of common interest, and 
thus encourage other research groups to use this 
“happy hunting ground”. 
 Asthma is a common chronic inflammatory disease 
of the airways characterized by variable and recurring 
symptoms, reversible airflow obstruction and broncho-
spasm. Common symptoms include wheezing, 
coughing, chest tightness, and shortness of breath. The 
development of asthma is most likely triggered by com-
plex interactions between genes and environment. The 
diagnosis is based on patterns of symptoms, response 
to therapy over time and spirometry. Asthma may also 
be classified as atopic (extrinsic) or non-atopic (intrin-
sic) (Global Strategy for Asthma Management and 
Prevention, Global Initiative for Asthma (GINA) 2014, 
http://www.ginasthma.org/). 
 The MoBa Asthma Group has already from 2007 to 
2014 published several papers based on data from 
MoBa. These publications are the basis for the present 
study Causal Pathways for Asthma (CASPAR) funded 
by the Research Council of Norway. It is hard to 
understand the underlying causal mechanisms for 
asthma. Thus we have focused our work on estimating 
the associations between different in utero exposures 
and different asthma related phenotypes including 
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early respiratory tract infections. 
 We found that there was no association between 
maternal alcohol intake during pregnancy and the risk 
of asthma in the off spring1. In contrast, higher ma-
ternal mid-pregnancy level of vitamin D classified as a 
25-hydroxyvitamin D level was associated with a 
modestly reduced risk of recurrent lower respiratory 
tract infections (LRTIs) by age three years, but was not 
associated with current asthma2. Furthermore, folic 
acid supplements in pregnancy were associated with a 
slightly increased risk of wheeze and lower respiratory 
tract infections up to 18 months of age3. Maternal folat 
levels also tended to be associated with an increased 
risk of asthma at age three4. These results suggest that 
methyl donors in the maternal diet during pregnancy 
may influence respiratory health in children consistent 
with epigenetic mechanisms. We found no association 
between oral contraceptive pill use before pregnancy 
and respiratory outcomes in early childhood5. In con-
trast, maternal smoking in pregnancy was associated 
with an increased risk of acute otitis media6, lower 
respiratory tract infections and wheezing symptoms 
during early childhood7. We have further reported that 
the risk of wheeze increased linearly with maternal 
BMI in pregnancy8. With regard to mode of delivery, 
results from MoBa indicated that children delivered by 
caesarean section had an increased risk of developing 
asthma9. Finally, participating in baby swimming may 
also be related to later wheeze among children10. 
 In conclusion, we have suggested that several expo-
sures during pregnancy and early childhood may be 
associated with early respiratory health outcomes. 
However, asthma is a heterogeneous disease. Conse-
quently, we need a better and more specific definition 
of asthma and asthma related phenotypes in school age 
to suggest that any of these exposures have an effect 
on childhood asthma. In the present study, CASPAR, 
we will thus take advantage of the basic MoBa samp-
les and infrastructure, including links to other national 
health registries such as the Medical Birth Registry of 
Norway (MBRN) and the Prescription registry 
(NorPD), and combine this information with measures 
of prenatal exposures in maternal plasma believed to 
have epigenetic influences on asthma and atopy, and 
data on methylation of cord blood DNA to contribute 
to build up knowledge on asthma pathogenesis. 
 
Epigenetics  
In simplified terms, epigenetics is the study of mecha-
nisms that will switch genes on and off. The term 
refers to heritable changes in gene expression (active 
versus inactive genes) that does not involve changes to 
the underlying DNA sequence; a change in phenotype 
without a change in genotype. Epigenetic change is a 
regular and natural occurrence but can also be influen-
ced by several factors including age, the environment/ 
lifestyle, and disease state. Epigenetic modifications 
can manifest as commonly as the manner in which 
cells terminally differentiate to end up as skin cells, 
liver cells, brain cells, etc. Epigenetic change can also 
have more damaging effects that can result in diseases 
like cancer. At least three systems including DNA 
methylation, histone modification and non-coding 
RNA (ncRNA) associated gene silencing is currently 
considered to initiate and sustain epigenetic change. 
New and ongoing research is continuously uncovering 
the role of epigenetics in a variety of human disorders 
and fatal diseases. 
 Epigenetic modification of DNA is emerging as a 
likely mechanism contributing also to the development 
of asthma and atopic phenotypes11,12 and provides as a 
plausible mechanism for effects of maternal diet on 
disease risk in the offspring. Mechanisms influencing 
methylation of DNA are complex and just beginning to 
be uncovered. Methylation, the best studied mechanism 
of epigenetic modification13, regulates protein activity 
and gene transcription14. It has been shown that dietary 
methyl supplementation in mice increases CpG methy-
lation of offspring DNA15 and silences certain genes16. 
The best established example is the Agouti mouse mo-
del in which maternal diet influences both coat colour 
and obesity in the offspring by means of hypermethy-
lation of the Aguoti gene17. It has also been shown that 
smoking during pregnancy is associated with DNA 
methylation in newborns18-20. NIPH and NIEHS have 
currently investigated the effects of maternal diet in 
pregnancy on asthma and atopy related diseases in the 
offspring up to age 3 years, and the findings indicate 
an association between maternal use of supplements in 
pregnancy and asthma and atopy related diseases in 
early childhood3,4. Other nutrients linked to respiratory 
disorders include folat, fish oil, and vitamins A, C, E 
and D3,4,21,22. 
 
AIM 
 
The aim of the present study is thus to examine a 
number of hypothesis regarding in utero and early life 
exposures in relation to the development of different 
phenotypes of asthma and allergies to advance know-
ledge of the mechanisms whereby diet and environ-
mental exposures, influences gene expression to alter 
risk of atopic disease. 
Objective 1: What is the association between expo-
sures during pregnancy, and the development of 
asthma/atopy in the offspring after age 7 years? 
Objective 2: What is the association between different 
exposures during pregnancy and cord blood DNA 
methylation?  
Objective 3: What is the association between cord 
blood DNA methylation and asthma/atopy after age 7 
years? 
Objective 4: Is an estimated association between in 
utero exposures mediated by child’s level of the same 
exposures? 
 
MATERIAL AND METHODS 
 
The study uses three different study populations to 
address the research questions of interest. 
 Study population I (N= 114 000) includes MoBa 
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participants with questionnaires filled out in the 18th, 
22nd and 30th gestational week, when the child is 6, 
18, and 36 months, in addition to 7 years. Information 
gathered includes demographic characteristics, mater-
nal and child morbidity, child development, environ-
mental exposures and diet. Study population II (N= 
3500) includes a subsample of MoBa with measures of 
maternal biological levels during pregnancy of 
different dietary and environmental exposures. Study 
population III (N=1800) includes asub sample of study 
population II where DNA methylation of cord blood 
has been analyzed. 
 Data from MoBa are also linked to the Medical 
Birth Registry of Norway (MBRN), to obtain informa-
tion on birth outcomes gathered at the time of delivery, 
in addition to the Prescription Registry (NorPD), with 
data on prescription drugs dispensed from all Norwe-
gian pharmacies since 2004. 
 
Variables  
The main outcomes are: 1) Asthma, 2) Asthma related 
phenotypes, 3) DNA methylation. The main exposures 
are: 1) Maternal dietary and environmental and health 
related exposures during pregnancy, 2) maternal 
plasma levels of dietary and environmental exposures, 
3) DNA methylation, 4) measures of levels of several 
dietary and environmental exposures in the children. 
Possible confounding factors and other factors related 
to the different research questions will be included in 
the analyses. 
 Analyses of biological samples: Bevital laboratory 
in Bergen (www.bevital.no) have analysed levels of 
methyl donor nutrients, vitamins and metabolites in 
samples from MoBa mothers included in study 
population II. DNA methylation is measured at 
485,577 cytosine positions (CpG sites) in cord blood 
using the Illumina Infinium HumanMethylation450 
BeadChip in study population III (Bibikova et al. 
2011; Sandoval et al. 2011). 
 
ORGANIZATION 
 
The present study is based on an ongoing collaboration 
that is established between the Norwegian Institute of 
Public Health (NIPH), the National Institute of Envi-
ronmental Health Sciences (NIEHS) in the US and 
several other national and international collaborators 
within the MoBa Asthma Group. The group has high 
scientific and organizational competencies, and repre-
sents several large institutions with an infrastructure 
that makes this study possible. The core study, MoBa, 
has its own organization and an extensive infrastruc-
ture (www.fhi.no/tema/morogbarn). 
 
PUBLIC HEALTH RELEVANCE 
 
The proposed study significantly enhances our under-
standing of the complex aetiology of asthma and atopy 
in childhood. Our study will contribute with substantial 
new knowledge to the international childhood asthma 
and atopy research. The information will be important 
in targeting health education and health promotion 
programs and useful for public health institutions and 
government offices involved in decision-making regar-
ding public health recommendations. Several countries 
are, for example, discussing fortification programs, and 
results from this study will add aspects to the discus-
sion. Both negative and positive results will contribute 
to the understanding of how micronutrients and other 
exposures affect metabolism and DNA modification. 
The publication plan includes scientific publications, 
to be published in high impact peer-reviewed scientific 
journals. All results will also be published on the 
websites of NIPH (www.fhi.no) and MoBa 
(www.fhi.no/tema/morogbarn). Results will also be 
included in specific newsletter to the participating 
mothers, fathers and their children. 
 
 
ETHICAL ASPECTS 
 
MoBa is previously approved by the Norwegian Data 
Inspectorate and recommended by the Regional Ethical 
Committee (REK). The linkage of MoBa to the 
MBRN and NorPD has the same approvals, and the 
women are informed of these linkages. The women are 
informed that they can withdraw at any time. The 
present study has also an approval from the Norwegian 
Data Inspectorate and recommended by the REK for 
this specific sub project, a new national supplementary 
study of MoBa, that include measures of prenatal 
exposures in maternal plasma believed to have epi-
genetic influences on asthma development and data on 
methylation of cord blood DNA and a follow-up of the 
children to age 7 years. Children are particularly im-
portant to ensure high quality care. The specific focus 
will be to develop and implement standards for epige-
netic studies including children and other participants 
in population-based cohorts (MoBa), emphasizing com-
munication with participants and the society at large, 
procedures for ensuring data security, and ethically 
robust approaches to epigenetic disclosure issues. 
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